COVID-19 and the race for a cure - Sentinelassam sentinelassam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sentinelassam.com Daily Mail and Mail on Sunday newspapers.
India News: Pfizer Inc has withdrawn an application for emergency-use authorization of its Covid-19 vaccine in India that it has developed with Germany's BioNTech
Pfizer withdraws COVID-19 vaccine application in India for this reason - Indian health officials say they ask for so-called bridging trials to determine if a vaccine is safe and generates immune response in its citizens.
https://data1.ibtimes.co.in/en/full/756826/prosecutors-dont-know-where-kenosha-shooter-kyle-rittenhouse.jpg
Prosecutors don t know where Kenosha shooter Kyle Rittenhouse is?IBTimes IN
Pfizer has decided to withdraw its application for Emergency Use Authorisation of its Covid-19 vaccine in India. In pursuance of the Emergency Use Authorisation of its Covid-19 vaccine, Pfizer participated in the Subject Expert Committee meeting of the Drug Regulatory Authority of India on February 3. Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time, a Pfizer spokesperson said. Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future. Pfizer remains committed to making its vaccine available for use by the Government in India and to pursuing the requisite pathway for e
Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator's demand for a local safety and immunogenicity study.